March 22, 2024 Quanterix Outlines Partner Path With Labs to Expedite Building Global Alzheimer’s Disease Testing Infrastructure read article
March 4, 2024 Quanterix Granted Breakthrough Device Designation from U.S. FDA for Blood-Based p-Tau 217 Test for Alzheimer’s Disease read article
February 29, 2024 Quanterix Releases Operating Results for Fourth Quarter and Full Year 2023 read article